Match Document Document Title
7208481 Aminodiphosphonate apolipoprotein E modulators  
The present invention relates to methods of use of aminodiphosphonate to modulate apolipoprotein E levels and the use of such compounds in therapy, including cardiovascular and neurological disease...
7202082 Immortalized preosteoblasts and method for their production  
The present invention relates to novel immortalized pre-osteoblast cell lines derived from the periost and capable of differentiate to osteoblasts. In particular, the present invention pertains to...
7198947 Production of functional proteins: balance of shear stress and gravity  
The present invention provides a method for production of functional proteins including hormones by renal cells in a three dimensional co-culture process responsive to shear stress using a rotating...
7195896 Complementary adenoviral vector systems and cell lines  
The present invention provides multiply deficient adenoviral vectors and complementing cell lines. Also provided are recombinants of the multiply deficient adenoviral vectors and a therapeutic...
7192768 Synchronization of the cytoplasmatic and the nuclear maturation of oocytes in vitro  
The present invention relates to a method for in vitro maturation of oocytes comprising the steps of: (a) culturing one or more GV oocytes in a culture medium, the culture medium comprising a...
7189561 Production of adenovirus vectors with reduced levels of replication competent adenovirus contamination  
Methods, cells and recombinant adenoviral vectors are disclosed that permit the production of recombinant adenoviral vector stocks with reduced levels of contamination by replication competent...
7189567 Method of culturing human chondrocytes  
This invention provides a method for rapidly culturing a large amount of human chondrocytes to give normal chondrocytes or a mass thereof. The culture method comprises co-culturing human...
7186558 Keratinocytes obtained from embryonic stem cells of mammals  
The present invention relates to a method for inducing the differentiation of mammals' embryonic stem cells into keratinocytes, comprising the following steps of: isolating an extracellular...
7186517 Compositions and methods for monitoring breast cancer treatment  
The present invention provides compositions and a method for monitoring breast cancer treatment.
7179649 Differentiation of adipose stromal cells into osteoblasts and uses thereof  
The invention provides methods and compositions for differentiating stromal cells from adipose tissue into cells having osteoblastic properties, and methods for improving a subject's bone...
7176182 Methods of enhancing functioning of the large intestine  
The invention relates to glucagon-related peptides and their use for the prevention or treatment of disorders involving the large intestine. In particular, it has now been demonstrated that GLP-2...
7176020 EBV-infected stomach cancer cell line  
An EBV strain infecting epithelial cells and a stomach cancer cell line cancerated by EBV are established to clarify the mechanism of canceration of epithelial cells into stomach cancer by EBV and...
7176022 Directly injectable formulations which provide enhanced cryoprotection of cell products  
This invention provides compositions and methods for cryoprotection of recombinant live cancer cells. Specifically, an improved cryoprotective medium is provided which includes a hydroxyethyl...
7175842 Methods of modulating hair growth  
The invention features methods of promoting hair growth in a subject. The methods include inducing or mimicking the effects of Wnt promoted signal transduction, e.g., by increasing the level of Wnt...
7176023 Endothelial cells derived from primate embryonic stem cells  
A method is described to induce primate embryonic stem cells to differentiate into a relatively homogenous population of endothelial cells. The ES derived endothelial cells have the general...
7169610 Serum-free media for chondrocytes and methods of use thereof  
The present invention provides defined serum-free cell culture media useful in culturing fibroblasts, especially articular chondrocytes, that avoids problems inherent in the use of serum-containing...
7169605 Methods of controlling proliferation and differentiation of stem and progenitor cells  
A method of ex-vivo expanding a population of stem cells, while at the same time inhibiting differentiation of the stem cells. The method comprises ex-vivo providing the stem cells with conditions...
7166445 Methods and host cells for improved cell culture  
The invention provides improved methods of recombinant protein production in cell culture. More specifically, the invention relates to the modulation of the IGF-1 signaling pathway in cells so as...
7166279 Myoblast transfer therapy for relieving pain and for treating behavioral and perceptive abnormalities  
An analgesic benefit is realized by continuously supplying a peptide in vivo that activates an opioid receptor or that interferes with the binding of substance P to its receptors. The long-term,...
7163787 Methods for the identification of antiviral compounds  
The present invention provides novel methods for determining whether a compound influences a phase in the life cycle of a virus comprising providing a cell with the compound and with at least a...
7163824 Regulation of endogenous gene expression in cells using zinc finger proteins  
The present invention provides methods for modulating expression of endogenous cellular genes using recombinant zinc finger proteins.
7160684 Methods of selecting compounds for modulation of bladder function  
The present invention involves an assay system and method of selecting compounds useful in the treatment of bladder instability and related bladder conditions through the activation of KCNQ...
7160722 Master bone formation transcription factor: compositions and methods of use  
A novel gene expressed selectively by osteoblast lines is provided. Expression of the gene is highly restricted to cells of osteoblast lineage, including precursor cells. Also provided is a method...
7160724 Human cord blood as a source of neural tissue for repair of the brain and spinal cord  
The present invention relates to the use of umbilical cord blood cells from a donor or patient to provide neural cells which may be used in transplantation. The isolated cells according to the...
7160726 Compositions comprising conditioned cell culture media and uses thereof  
The invention relates to compositions comprising cell culture medium conditioned by cells grown in three-dimensional culture. The cells used to condition the medium may be genetically modified to...
7157438 Rhob as a suppressor of cancer cell growth and cell transformation  
The protein RhoB and its variants as a supressor of cancer cell growth, inhibitor of malignant cell transformation, and modulator of oncogenic signaling, wherein introducing RhoB directly, or...
7157566 Monomeric and dimeric fluorescent protein variants and methods for making same  
The present invention relates generally to variant fluorescent proteins, and more specifically to monomeric and dimeric forms of Anthozoan fluorescent proteins. In one aspect, the present invention...
7157278 Cultured cells from pancreatic islets  
A cell composition of endocrine progenitor cells derived from mammalian pancreatic islet cells that can be trans-planted into a diabetic patient such that the cells of the cell composition...
7153648 Dielectrophoretic separation of stained cells  
This invention relates generally to the field of cell separation or isolation. In particular, the invention provides a method for separating cells, which method comprises: a) selectively staining...
7148062 Method for generating primate trophoblasts  
The first method to cause a culture of human and other primate stem cells to directly and uniformly differentiate into a committed cell lineage is disclosed. Treatment of primate stem cells with a...
7144729 Methods and compositions for tissue regeneration  
The present invention provides the use and composition of matter of angiogenic or other growth/cytokine factors expressed by mixtures of allogeneic human cell strains or lines of various types and...
7138275 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use  
The invention relates to the production of adult dedifferentiated, programmable stem cells from human monocytes by cultivation of monocytes in a culture medium which contains M-CSF and IL-3. The...
7135463 RHoB as a suppressor of cancer cell growth, cell transformation, and metastasis  
The present invention concerns the use of the protein RhoB and its variants to inhibit cancer cell growth, migration, invasion, metastasis, malignant cell transformation, and/or to modulate...
7132243 Clonal expansion of T cells of unknown specificity and identification of ligand recognized by the clonally expanded T cells  
A process for clonally expanding T cells of unknown specificity and a process for identifying a peptide ligand recognized by said T cells are provided. A process for clonally expanding T cells of...
7132285 Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders  
Treatment and/or prophylaxis, in mammalian patients, of neurodegenerative and other neurological medical disorders is effected by administering to the patient effective amounts of apoptotic bodies...
7132288 Medium for culturing tumor cells  
Disclosed is a medium for cultivating tumor cells, comprising the following constituents, as comprised for example in the medium RPMI 1640: (a) fetal calf serum (FCS), (b) penicillin-streptomycin,...
7132284 Adenovirus packaging cell lines  
Adenovirus packaging cell lines for growth of an E1A/E1B deficient adenovirus that is substantially free of replication competent adenovirus (RCA) are provided. Methods for producing adenovirus...
7129086 Human marrow stromal cell lines which sustain hematopoiesis  
Immortalized human stromal cell lines sustain and expand human hematopoietic precursor cells. The precursor cells are obtained from a blood product and inoculated into a culture medium conditioned...
7125713 Human mullerian duct-derived epithelial cells and methods of isolation and uses thereof  
This invention discloses a substantially pure population of human Müllerian duct-derived epithelial cells and methods of isolating and culturing the Müllerian duct-derived epithelial cells. By...
7122180 DNA vectors containing mutated HIV proviruses  
The present invention pertains to mutated, non-infectious HIV viral particles, vectors for production of such particles and vaccines employing such vectors. The non-infectious particles are...
7122208 Compositions containing apoptotic entities  
Disclosed are methods for treating and preventing neurological disorders which have a significant inflammatory component. The methods of the present invention involve extracting blood from a...
7115417 Soft tissue and bone augmentation and bulking utilizing muscle-derived progenito compositions, and treatments thereof  
The present invention provides muscle-derived progenitor cells that show long-term survival following transplantation into body tissues and which can augment soft tissue following introduction...
7115360 Isolation and use of solid tumor stem cells  
A small percentage of cells within an established solid tumor have the properties of stem cells. These solid tumor stem cells give rise both to more tumor stem cells and to the majority of cells in...
7112653 Composition and method for preserving progenitor cells  
The invention relates to a protein material which is effective to preserve progenitor cells, such as hematopoietic progenitor cells. The protein has an amino acid sequence comprising AQSLSFSFTKFD...
7109031 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells  
A method for inducing differentiation of monocytes contained in an extracorporeal quantity of a subject's blood into functional dendritic antigen presenting cells is provided. The monocytes are...
7109026 Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment  
The present invention concerns a use of a MHC class II ligand, such as CD4 and LAG-3, for the manufacture of a medicament for preventing or treating pathological conditions involving an antigen...
7109029 Vector constructs  
The present invention provides novel viral vectors and methods useful for the minimization of leaky gene expression, and, in particular, of nonspecific transcriptional read-through of genes. Such...
7105346 Packaging systems for human recombinant adenovirus to be used in gene therapy  
Presented are ways to address the problem of replication competent adenovirus in adenoviral production for use with, for example, gene therapy. Packaging cells having no overlapping sequences with...
7105345 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same  
The nucleic acid sequences of adeno-associated virus (AAV) serotype 1 are provided, as are vectors and host cells containing these sequences and functional fragments thereof. Also provided are...
7105170 Latent human tuberculosis model, diagnostic antigens, and methods of use  
Provided herein is an in vitro granuloma model and methods of its use. Methods of detecting and/or diagnosing latent tuberculosis in a subject are also provided, as are latency-specific antigens...